ClinicalTrials.Veeva

Menu

Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases (BLEND)

U

UMC Utrecht

Status and phase

Completed
Phase 2
Phase 1

Conditions

Neoplasm Metastasis

Treatments

Procedure: BLEND

Study type

Interventional

Funder types

Other

Identifiers

NCT02622841
NL51405.041.15

Details and patient eligibility

About

The aim of this study is to assess the feasibility and safety of combining stereotactic body radiotherapy (SBRT) and pedicle screw fixation in a 48-hour window for the treatment of painful unstable metastases of the thoracic and/or lumbar spine.

Full description

Rationale: Sixty-five percent of cancer patients with terminal illness have bone metastases, with debilitating pain as devastating consequence. The spine is the most common location for bone metastases. Spinal cord compression is present in 10% of patients with vertebral metastases and aggravates pain and performance status even further. Standard treatment of unstable vertebral metastases consists of stabilizing surgery, followed by external beam radiotherapy (8 Gy) after two weeks. Although this approach is effective in 60-70% of patients, it is has several downsides. Firstly, because of the two weeks interval between surgery and external beam radiotherapy, necessary for sufficient wound healing, it takes a long time before radiotherapy induced pain relief is achieved. Scatter artifacts on planning computed tomography images caused by surgical implants prohibit high-resolution imaging and accurate targeting of the lesion. Multiple hospital visits (+/- 10) are needed for administration of external beam irradiation, and in about 30-40% of patients no adequate pain response is achieved. An alternative treatment strategy, which would lead to faster pain relief in a higher proportion of patients with less hospital visits, would be highly desirable from the patient's perspective.

Objective: To assess the feasibility and safety of combining stereotactic body radiotherapy (SBRT) and pedicle screw fixation in a 48-hour window for the treatment of painful unstable metastases of the thoracic and/or lumbar spine.

Study design: Prospective case series (13), first in man study, Phase I and II a study according to the IDEAL recommendations

Study population: All patients, male and female, with impending spinal stability requiring radiation therapy and surgical intervention at the University Medical Center Utrecht

Main study parameters/endpoints: The main outcome of this study is safety of the combined procedure, defined as grade 3 or higher treatment-induced toxicity according to common terminology criteria for adverse events (CTC-AE) 4.0 as a result of the procedure within 60 days after the surgery.

Enrollment

13 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Painful metastases from solid tumors in the thoracic or lumbar spine needing surgical stabilization
  • Histologic proof of malignancy
  • Radiographic evidence of spinal metastases
  • Karnofsky performance status ≤ 50
  • Written informed consent

Exclusion criteria

  • Multiple spinal metastases necessitating bridging more than five vertebral levels during surgery
  • Previous surgery or radiotherapy to index lesion
  • stereotactic body radiotherapy cannot be delivered (Bilsky score 2 and 3)
  • Neurological deficits (ASIA C, B or A)
  • Partial neurological deficits (ASIA D) with rapid progression (hours to days)
  • Inability to lie flat on table for stereotactic body radiotherapy
  • Non-ambulatory patients
  • Patient in hospice or with < 3 months life expectancy
  • Medically inoperable or patient refused surgery

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

BLEND
Experimental group
Description:
Combination of stereotactic bodyradiotherapy and surgical stabilization within 48 hours for the treatment of unstable spinal metastases.
Treatment:
Procedure: BLEND

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems